Rapid Approval of Drugs to Bode Well for Global Dravet Syndrome Market: MRFR

Dravet syndrome is a rare epileptic disorder affecting infants. The patient has seizures which are triggered by hot temperatures or fevers. It is also known as severe myoclonic epilepsy of infancy (SMEI). According to the National Center for Advancing Sciences, nearly 15-25% of the cases of the disorder have a family history of febrile seizures or epilepsy. The global Dravet syndrome market report by Market Research Future (MRFR) has been compiled by a blend of primary and secondary research.

Market Overview

The global Dravet Syndrome Market is expected to magnify its valuation at 8.5% CAGR from 2017 to 2023 (forecast period). The increase noticed in the health expenditure for research and development (R&D) and development of new therapies are primary factors expected to drive the market growth. Other major drivers include reimbursement policies offering coverage of rare diseases, improvement in regulatory framework, and unmet medical needs of patients.

Adverse effects of the drugs, low awareness of the disease, and low planning of healthcare in low and mid income countries are some of the restraints which can impede market growth.

Request For Sample Report: https://www.marketresearchfuture.com/sample_request/5509

Segmentation

The global Dravet syndrome market is segmented on the basis of the type of seizures, diagnosis, treatment & management, and end-user.

On the basis of the type of seizures, it is classified as myoclonic seizures, atonic seizures, partial seizures, absence seizures, tonic clonic seizures, photosensitive seizures, and others.

On the basis of the diagnosis, it is segmented as magnetic resonance imaging (MRI), electroencephalography (EEG), SCN1A testing, and others.

On the basis of the treatment & management, the market is segmented into seizure medications, ketogenic diet, vagus nerve stimulation (VNS), and others. The seizure medications segment is further classified into clobazam, stiripentol, sodium valproate, and others.

On the basis of the end-user, the global Dravet syndrome market is segmented into pharmaceutical companies, hospitals, diagnostic laboratories, academic and research institutes, and others.

Global Capsule Endoscopy Market expected to register at CAGR of 8.82% and is anticipated to reach USD 967.4 million by 2023 | Emerging Technologies, Competition & Strategies of Key Players, Regional Analysis and Region Wise Performance

Capsule endoscopy, a digestive capsule-encased micro-camera is used to diagnosis gastrointestinal complications such as chronic pain, small intestinal bleeding, ulcer, and abnormal tissue growth where the traditional endoscopy is ineffective.  This diagnostic procedure images the esophagus, stomach, and small intestine as the device pass through the gastrointestinal (GI) tract. The real-time data provided by the capsule is used to expedite the diagnosis process and hence, the faster treatment and recovery in the gastrointestinal complications.

Resultantly, the uptake of capsule endoscopy is widening rapidly over the past few years. The larger absorption leads to driving the growth of capsule endoscopy market. Moreover, technological advancements transpired into the field of medical science are escalating the market on the global platform.

Acknowledging the enormous growth, the market perceives currently; Market Research Future (MRFR) in its newly published study report confirms that the global capsule endoscopy market is expected to garner exponential accruals posting a CAGR over 8.7% throughout the assessment period (2018-2023).

Additionally, factors such as the growing prevalence of intestinal diseases and cancerous tumors & diseases substantiate market growth. The rapidly changing lifestyle of people and their inclination towards the sedentary lifestyle is acting as a significant tailwind pushing up market growth, increasing the occurrences of gastrointestinal diseases and stomach cancer.

Substantial investments put into the R&D activities to bring the betterments in the endoscopy are, in turn, driving the market growth to an extent. Also, favorable reimbursement policies alongside government funding are playing a significant role in the growth of the capsule endoscopy market.

On the flip side, factors such as the high cost associated with the capsule endoscopy procedures and limited reimbursement along with the risk of capsule retention are impeding the market growth. Besides, the low awareness among physicians about the benefits of capsule endoscopy is a dominant factor hampering the market growth, acting as a major headwind.

Request For Free Sample Report: https://www.marketresearchfuture.com/sample_request/1359

Global Capsule Endoscopy Market – Segmentations

The MRFR analysis is segmented into five key dynamics for enhanced understanding.

By Type                 : Workstation, Wireless Capsule Endoscopy, Receiver Capsule Endoscopy, and others.

By Purpose            : Treatment, Investigation, Diagnostics, and others.

By Application       : Intestine Disease, Crohn's Disease, GIT Bleeding, and others.

By End-user           : Diagnostic Centers, Clinics & Hospitals, Medical Research Institutes, and others.

By Regions             : Asia Pacific, North America, Europe, and the Rest-of-the-World.

Gallstone Market Research Forecast, Regional, Trends and Analysis to 2023

Market Overview

According to a new report by Market Research Future (MRFR), the global gallstone market has been anticipated to expand at 7.9 % CAGR during the forecast period (2017-2022) owing to the increase in gallbladder diseases globally. Gallstones develop due to chemical imbalance of bile inside the gallbladder. Stones generally formed as the cholesterol level in bile increases and the cholesterol forms into stones. It has been predicted that in the UK, more than one in every ten adults suffer from gallstones. Around 80 % of the people suffering from gallstones don’t have pain as these are silent gallstones, asserts American College of Gastroenterology.

Future Drivers and Restraints Impacting the Market

Major causes of gallstones comprise blood sugar imbalance, estrogen dominance, food allergies and sensitivities, chronic stress, low fiber diet, low stomach acid production, obesity, rapid weight loss, low-fat diet, cholesterol-lowering medications, and others. Moreover, the continuous changing lifestyle coupled with unhealthy eating habits are also some of the major factors propelling the market growth. With increasing demand for treatment options, the gallstone market is likely to expand. Companies are developing cost-effective products that have minimum side effect. Several companies are also adopting strategies for acquisitions and launching new products to strive in the competitive market. The competition amongst new market players is also expected to upsurge the market growth.

Meanwhile, complications such as infection, bleeding, bile leakage, bile duct injury, deep vein thrombosis, post-cholecystectomy, and pain during the surgery along with asymptomatic nature of gallstones are predicted to slow down the market growth over the assessment period.

Request For Free Sample Report: https://www.marketresearchfuture.com/sample_request/1935

Global Gallstone Market Segmentation

Globally, the gallstone market has been segmented based on cause, diagnosis, treatment, and region.

The market has been segmented into bilirubin, cholesterol stones, concentrated bile, and others based on cause. The most common type is the cholesterol gallstone which appears in yellow and is mainly composed of undissolved cholesterols. According to World Gastroenterology Organisation, more than 85 % gallstones are cholesterol stones in developed countries, among which around 20 million people in the US suffer from gallstones.

Different diagnostic procedures covered in the market include abdominal CT scan, ultrasound, blood tests, gallbladder radionuclide scan, and others. The ultrasound is the most commonly used diagnostic procedure for gallstone diseases. With this procedure, even the smallest gallstones can be detected.

The market has also been segmented into laparoscopic cholecystectomy, open cholecystectomy, medications, and others based on treatment.

North America Estimated to Hold the Largest Share

Geographically, the market for gallstones has been spanned across North America, Europe, Asia Pacific, and the Middle East and Africa.

North America has been estimated to hold the largest share due to the presence of huge patient population suffering from gallbladder disease. High spending on healthcare along with a well-developed healthcare sector has contributed to the global market positively.

Europe holds the second largest position owing to the increased government for research and development. The UK, Germany, and France are the major contributors in this region. Ultrasound studies revealed an incidence of 0.63/100 persons per year and a prevalence of 9 to 21% in the European region, asserts World Gastroenterology Organisation.

Browse Complete Report: https://www.marketresearchfuture.com/reports/gallstone-market-1935

Moreover, Asia Pacific is anticipated to showcase the fastest growth rate due to the presence of huge patient population, improved healthcare infrastructure, and raising awareness associated with gallbladder diseases. Meanwhile, the Middle East and Africa account for the lowest market share in the gallstone market globally.

Competition Analysis

The prominent players operating the growth of the market comprise NovaTract Surgical LLC (California), Sklar Surgical Instruments (US), Olympus America Inc. (U.S.), Medtronic plc (Ireland), Intuitive Surgical Inc. (California), Fortimedix Surgical, Levita Magnetics (California), Simulab Corporation (US), and others.

Cosmetic Implant Market : Key Players, Growth, Analysis by 2019 – 2023

Overview:

Improving physical appearance can boost an individual’s confidence or help him or her recover from accidental wounds or trauma. Cosmetic implants work in that direction where by, placing substances under the skin or over it, doctors can achieve desired results. These implants are specially designed medical devices that can be subdermal or transdermal depending upon the surgical procedure.

The global cosmetic implant market is expected to grow at a healthy rate of 7.1% during the forecast period (2016-2022) to reach a valuation of USD 11.2 billion. The report published by Market Research Future (MRFR) contains drivers such as technological advancements which include injectable fillers and gummy bear implants and witnesses minimally invasive surgeries revolutionizing system. Furthermore, people getting conscious about their looks and rising amount of disposable income are considerably boosting the cosmetic implants market.

Request For Free Sample Report: https://www.marketresearchfuture.com/sample_request/2018

However, the high cost associated with the procedure and implant malfunction can halt the cosmetic implant market growth during the forecast period.

Industry Trends:

CAD-CAM system is revamping the dental implant industry as this can make a replica of the tooth that needs a transplant. This improves efficiency, reduces waiting time, and cuts down the cost significantly.

Ideal implants have recently launched saline-based breast implants whose unique construction would let women know of ruptures without an MRI scan. These implants also reduce wrinkling and rippling.

Segmentation:

The global cosmetic implant market can be segmented by type, material, and end-user.

By type, the cosmetic implant market includes dental implant, breast implant, facial implant, buttock implant, and others.

Material-wise, the cosmetic implant market comprises polymers, metals, ceramics, and biologicals.

Based on end-users, the market can be segmented into hospitals, dental clinics, academics, and others.

Regional Analysis:

Region-specific analysis of the global cosmetic implant market includes North America, Europe, Asia Pacific (APAC), and the Rest-of-the-World (RoW).

North America has the largest market for cosmetic implants. Superior healthcare infrastructure backed by latest technologies has given the market enough space to expand and draw in revenue. High healthcare investment and growing general awareness are also drivers that are giving the regional market much traction.

Europe has the second largest market. The region mostly follows the steps of North America. Likewise, the region is investing heavily in researches which are easing the regional market’s growth path.

The APAC region is experiencing a revolution in healthcare and increasing investment in the sector is ensuring cosmetic implants prospect in coming years. The region can clock the fastest CAGR during the forecast period.

For More Details Browse Complete Report @ https://www.marketresearchfuture.com/reports/cosmetic-implant-market-2018

Market Landscape:

The cosmetic implant market has several international players that are helping the growth of the global market. However, regional players are also contributing significantly and are creating many opportunities for the market to accelerate its grassroot level penetration. Important strategies include mergers, acquisitions, joint ventures, product launches, and others. For instance, Sientra has recently received approval from FDA to launch their breast implant line Opus. On the other hand, New York’s Hospital for Special Surgery and pSivida have collaborated in their effort to create a knee implant to improve knee osteoarthritis pain. 

Some of the key players in this market are LABORATOIRES ARION, CEREPLAS, 3M, Institut Straumann AG, Zimmer Holdings, Inc., Nobel Biocare Holding AG, DENTSPLY Implant, ALLERGAN, INC., Spectrum Designs Medical, Dyna Dental, Cortex Dental Implant Industries Ltd., AART.Inc and many others.

Cardiac Tamponade Market : Key Players, Growth, Analysis by 2019 – 2023

Market Highlights:

Cardiac tamponade, is the build-up of fluid in the sac around the heart (pericardium) resulting in pressure and difficulty in compression of the heart. Difficulty in compression of the heart results in reduced blood volume to be pumped by the heart. The symptoms of cardiac tamponade include shortness of breath, weakness, light-headedness, cough, fatigue, swelling of the abdomen, veins in the arms or legs, or other areas, pale skin, or skin that is blue- or gray-tinted, rapid heartbeat, anxiety or restlessness, fainting etc. The causes of cardiac tamponade are cancer, kidney failure, chest trauma, and pericarditis, connective tissue diseases, hypothyroidism, aortic rupture, following cardiac surgery, tuberculosis etc. Cardiac tamponade can be life-threatening if not treated. Risk factors which increases the chances of cardiac tamponade include heart surgery, heart attack, injury to the heart, end-stage lung cancer, radiation therapy to the chest, hypothyroidism, systemic lupus erythematosus etc.

The diagnosis segment of cardiac tamponade especially the non-invasive Magnetic Resonance Imaging (MRI) is growing fast. Magnetic Resonance Imaging (MRI) is the diagnostic test of choice. The surgery segment is led by pericardiocentesis which involves drainage of the fluid by use of a needle. Cardiac tamponade has a frequency of approximately 2 per 10,000 per year in the US.

Request For Free Sample Report: https://www.marketresearchfuture.com/sample_request/4341 

The market drivers for cardiac tamponade market are increasing cardiac cases such as heart attack, other factors includes cancer, kidney failure, end-stage lung cancer, hypothyroidism, rising screening and penetration of healthcare, growing awareness about cardiac diseases and growing income and healthcare expenditure etc. The market restraints are cost of cardiac tamponade surgery, complications and risk of the surgery, invasive nature of treatment etc.

Global Cardiac tamponade Market Players

Key players profiled in the report are Boston Scientific Corporation, Medtronic, Inc., St. Jude Medical Inc., Hitachi, Ltd., Koninklijke Philips N.V., Siemens Healthcare Private Limited, and Toshiba Medical Systems Corporation, General Electric Company, and others.

Regional Analysis

The Americas accounts for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new drugs in the US drives the cardiac tamponade market. Also, concentration of major research companies in the developed countries of this region is adding fuel to the market growth. The large US expenditure on healthcare accounting to 16% of GDP also cruises the sale of cardiac tamponade treatment. The large number of specialized cardiac centres in the US also drives the market.

Europe is the second largest market in the world due to high income and healthcare penetration. Europe is led by nations such as Germany and France. UK is expected to be the fastest growing market.

Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.

Access Complete Report @ https://www.marketresearchfuture.com/reports/cardiac-tamponade-market-4341

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The development of large hospitals such as the King Fahd hospital in Riyadh is driving the market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.

Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Cardiac tamponade Market” Research Report – Forecast till 2023.

Segmentation

The global cardiac tamponade market has been segmented on the basis of diagnosis, treatment, and end user.

Based on diagnosis, the market has been segmented as X-ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), coronary angiography, electrocardiogram (EKG), and others.

Based on treatment, the market has been segmented as surgery and drugs. The surgery segment has been sub-segmented as pericardiocentesis, thoracotomy and others. The drugs segment has been sub-segmented as antibiotics, blood volume expanders and others.

Based on the end user, the market has been segmented as hospitals & clinics, academic and research and others.

Autoimmune Diseases Market : Key Players, Growth, Analysis by 2019 – 2023

Market Potential and Pitfalls

The global autoimmune disease diagnostics market is likely to experience an upsurge owing to the increased prevalence of autoimmune disease, surging awareness regarding autoimmune diseases, and rising expenditure on healthcare. The increasing spending on R&D activities coupled with the aggressive strategies adopted by the top market players like new product launches along with mergers and acquisitions are anticipated to contribute to the market growth across the globe. For instance, Abbott acquired Alere Inc. in October 2017 for USD 5300 million. The deal will enable Abbott to gain control over USD 7000 million diagnostics sales of Alere Inc. and also strengthen their position in the global market.

The increasing occurrences of several diseases like rheumatoid arthritis and Hashimoto’s thyroiditis are likely to influence the market across the globe. Several initiatives taken by the government regarding autoimmune disease diagnosis are further contributing to its growth. As per the American Autoimmune Related Diseases Association, approximately 50 million people from America are suffering from autoimmune related disorders. Such factors are likely to create immense opportunities to the growth of the market.

On the contrary, the surging false positive results along with the price war among the companies are the top barriers likely to vitiate the market growth to some extent during the appraisal period. Moreover, the dearth of education and experience of the lab personnel in diagnosing certain autoimmune diseases are further estimated to slow down the market growth.

Request For Free Sample Report: https://www.marketresearchfuture.com/sample_request/6715

Market Synopsis

Market Research Future (MRFR) asserts that the global autoimmune disease diagnostics market is likely to register a CAGR of 7.6% during the forecast period (2018-2023) owing to an increased prevalence of autoimmune diseases worldwide. Autoimmune disease is considered as a disorder where the body’s own immune system starts to attack the healthy cells in place of the foreign particles and disease-causing agents. Auto antibody test, antinuclear antibody test, complete blood count, C-reactive protein, and erythrocyte sedimentation rate are some of the tests performed for diagnosis of the autoimmune disease.

Global Autoimmune Disease Diagnostics Market: Segmental Analysis

The global autoimmune disease diagnostics market has been segmented on the basis of test type, disease type, and end-user.

By mode of disease type, the global autoimmune disease diagnostics market has been segmented into systemic autoimmune disease, and localized autoimmune disease. Among these, the localized autoimmune disease segment is likely to gain prominence owing to the presence of large procedure volume and higher patient awareness level.

By mode of test type, the global autoimmune disease diagnostics market has been segmented into enzyme-linked immunosorbent assay (ELISA), western blotting, dot blot, double immune diffusion, line blot, counter immune-electrophoresis, multiplex immunoassay, immunofluorescence assays (IFA), agglutination, and others.

By mode of end-users, the global autoimmune disease diagnostics market has been segmented into diagnostics centers, hospitals, research laboratories, and others.

For More Details Browse Complete Report @ https://www.marketresearchfuture.com/reports/autoimmune-disease-diagnostics-market-6715

Regional Insights

Geographically, the autoimmune disease diagnostics market span across regions namely, Europe, America, Asia-Pacific, and the Middle East & Africa.

Considering the global scenario, the American region is predicted to command the maximum share in the global market. The region is likely to retain its pole position owing to the surging prevalence of autoimmune diseases like rheumatoid arthritis. Moreover, the rising financial support by the private organizations and governments coupled with the adoption of high advanced technology in this region is anticipated to contribute to the growth of the market. As per a report published by the Arthritis Foundation in 2017, around 91 million Americans were suffering from arthritis, 300000 of them were children.

The European region is predicted to occupy the second spot in the global market owing to the increased automation in the laboratories, rising healthcare industry, and strategies implemented by the top market players like mergers & acquisitions and product launches.

The Asia Pacific region is likely to expand at the fastest growth rate during the assessment period. The growth can be ascribed to the inflating population, rising private-public partnerships for the improvement of the healthcare sector, and surging prevalence of autoimmune disorders in this region.

Industry Updates

March 27, 2019: Eli Lilly is planning to partner with ImmuNext in order to study and develop a preclinical novel potential target for the treatment of autoimmune disease through an up-to-$605 million-plus collaboration.

Competitive Dashboard

The prominent players operating in the global autoimmune disease diagnostics market comprises bioMérieux SA, Siemens Healthcare Private Limited, Beckman Coulter Inc., Bio-rad Laboratories, EUROIMMUN AG, AstraZeneca, Inova Diagnostics Inc., F. Hoffmann-la Roche, Thermo Fisher Scientific, Myriad Genetics Inc., Hemagen Diagnostics Inc., and Trinity Biotech Plc.

Anti-Aging Services Market : Key Players, Growth, Analysis by 2019 – 2023

Market Highlights:

Increasing elderly population, growing desire to stay young is one of the most important factors that drive the growth of the anti-aging services market. According to the world health organization (WHO), the proportion of the world's population over 60 years between 2015 and 2050 will nearly double from 12% to 22%. Further, as per WHO estimates by 2020, the number of people aged 60 years and older will outnumber children younger than 5 years and by 2050, 80% of older people will be living in low- and middle-income countries. Besides that, factors such as growing demand for anti-aging drugs and services, the influence of media and fashion industry, increasing disposable income, growing awareness about the aesthetical industry are driving the market for anti-aging services.

On the other hand, the high cost of some of the procedures, and potential side effects of the anti-aging treatments are some of the factors that thwart the growth of the anti-aging services market to an extent.

Global Anti-aging Services Market held a market value of USD 21.39 billion in 2017 and is projected to grow at a CAGR of 5.47% over the forecast period.

Regional Analysis:

Geographically, the Americas is anticipated to dominate the global Anti-aging Services Market owing to the well-developed healthcare infrastructure, high disposable income, high awareness about the body aesthetics, and increasing adoption of the anti-aging services by people in the US. Moreover, the huge influence of the fashion and film industry in the US has played an important role in generating demand for the beauty and aesthetic services including anti-aging. All these factors are responsible for the growth in the region.

Europe is expected to hold the second largest market share in the global Anti-aging Services Market. The market growth in this region is majorly attributed to the growing popularity of aesthetic treatments, a high number of old age people, and increasing acceptance of anti-aging treatments in the region. Similarly, the Asia-Pacific region has observed a rapid growth in the anti-aging services market owing to the growing disposable income and demand for cost-effective anti-aging service. Besides, increasing

beauty consciousness in developing countries and rapidly growing medical tourism industry is also expected to generate growth opportunities in the untapped markets of the Asia-Pacific region. The Middle East & Africa region is anticipated to show minor growth opportunities in the anti-aging services market during the forecast period.

Request For Free Sample Report: https://www.marketresearchfuture.com/sample_request/7579

Segmentation:

The global anti-aging services market has been segmented into type of service and service provider.

Based on type of service, the market has been segmented into microdermabrasion, breast augmentation, liposuction, chemical peel, sclerotherapy, intense pulsed light, Botox treatment, dermal fillers, and others. The microdermabrasion segment is expected to account for the largest share in the global anti-aging services market in 2017. This large share is majorly attributed to the wider acceptance of the procedure, increasing acceptance in different regions, better patient compliance and better results as compared to other services. Liposuction segment is projected to hold the second largest market during the forecast period of 2018 to 2023.

Based on service providers, the market has been segmented into hospitals, dermatology clinics, salons, and others. The dermatology clinics segment is expected to account for the largest share in the global anti-aging services market in 2017 followed by hospitals segment. The major share of the dermatology clinics is mainly attributed to the wide range of anti-aging services provided by these specialty clinics and

Based on the regions, the market for hair removal devices is segmented into, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Anti-aging Services Market in the Americas region has further been segmented into North America and Latin America, where-in the North American market is further divided into the US and Canada.

European Anti-aging Services Market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The Anti-aging Services Market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Anti-aging Services Market in the Middle East & Africa has been segmented into regions such as the Middle East and Africa.

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/anti-aging-services-market-7579

Key Players:

Some of the prominent players in the global anti-aging services market are Allergan Inc., Alma Lasers, Beiersdorf AG, Cutera Inc., Cynosure Inc., Elizabeth Arden, Estee Lauder Inc., Lumenis, Procter & Gamble, Solta Medical Inc., and others.